Enterprise value:
$4.02B+$106.23M(+2.71%)Summary
- As of today (June 25, 2025), CRSP enterprise value is $4.02 billion, with a rise of +$106.23 million (+2.71%) during the most recent trading session on June 24, 2025.
- Over the past year, CRSP enterprise value has dropped by -$305.35 million (-7.05%).
- CRSP enterprise value is now -72.09% below its all-time high of $14.42 billion.
Performance
CRSP Enterprise value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Enterprise value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
CRSP Enterprise value Trends
PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
---|---|---|---|
todaytoday | +2.7% | +2.7% | +2.7% |
1 m1 month | +27.1% | +26.9% | +26.9% |
3 m3 months | - | +10.0% | +9.8% |
6 m6 months | +15.1% | +15.6% | +14.3% |
ytdytd | +22.0% | +19.8% | +18.9% |
1 y1 year | -7.0% | -15.9% | -19.3% |
5 y5 years | +9.1% | -10.8% | -36.0% |
CRSP Enterprise value Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | $4.02B | at high | $3.12B | +29.1% |
3 m | 3-month | $4.02B | at high | $2.85B | +41.3% |
6 m | 6-month | $4.47B | -10.0% | $2.85B | +41.3% |
1 y | 1-year | $5.12B | -21.4% | $2.85B | +41.3% |
3 y | 3-year | $7.36B | -45.4% | $2.79B | +44.0% |
5 y | 5-year | $14.42B | -72.1% | $2.79B | +44.0% |
alltime | all time | $14.42B | -72.1% | $256M | +1472.6% |
CRSP Enterprise value History
Date | Value |
---|---|
2025 | $4.02B(+22.0%) |
2024 | $3.30B(-32.3%) |
2023 | $4.88B(+47.2%) |
2022 | $3.31B(-35.5%) |
2021 | $5.14B(-49.7%) |
Date | Value |
---|---|
2020 | $10.21B(+263.2%) |
2019 | $2.81B(+174.3%) |
2018 | $1.02B(+43.7%) |
2017 | $713.35M(+45.8%) |
2016 | $489.20M |
FAQ
- What is CRISPR Therapeutics AG enterprise value?
- What is the all time high enterprise value for CRISPR Therapeutics AG?
- What is CRSP enterprise value year-to-date change?
- What is CRISPR Therapeutics AG enterprise value year-on-year change?
What is CRISPR Therapeutics AG enterprise value?
The current enterprise value of CRSP is $4.02B
What is the all time high enterprise value for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high enterprise value is $14.42B
What is CRSP enterprise value year-to-date change?
CRISPR Therapeutics AG enterprise value has changed by +$725.74M (+22.00%) since the beginning of the year
What is CRISPR Therapeutics AG enterprise value year-on-year change?
Over the past year, CRSP enterprise value has changed by -$305.35M (-7.05%)